Search clinical trials for: Tandem t:slim Insulin Pump with Control-IQ Technology

Total 170967 results

Hoffmann-La Roche
Roche Diabetes Care GmbH

Completed

Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes (Insight Kids)

Diabetes Mellitus Type 1

Germany, Austria, United Kingdom
Massachusetts General Hospital
Boston University

Completed

A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas

Diabetes Mellitus Type 1

United States
Novo Nordisk A/S

Completed

A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes (onset® 4)

Diabetes | Diabetes Mellitus, Type 1

United States, Germany
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
Juvenile Diabetes Research Foundation

Withdrawn

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Massachusetts General Hospital
Boston University

Completed

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Type 1 Diabetes

United States
University Hospital, Grenoble

Completed

Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia (ALPPHY)

Diabetes, Type 1

France
Massachusetts General Hospital
Boston University

Completed

The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas

Type 1 Diabetes

United States
Animas Corporation

Completed

Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting

Type 1 Diabetes Mellitus

United States
Massachusetts General Hospital
Boston University

Completed

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

Type 1 Diabetes

United States
Eli Lilly and Company

Withdrawn

A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Diabetes Mellitus, Type 1
Medtronic Diabetes

Completed

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes (STAR1)

Type 1 Diabetes

United States
Chinese PLA General Hospital

Completed

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Insulin Pump Therapy in Treating Diabetic Nephropathy
Indiana University
Juvenile Diabetes Research Foundation

Completed

Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes

Type 1 Diabetes

United States
University of Alabama at Birmingham

Completed

Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM

Type 1 Diabetes Mellitus

United States
Clinical Research Centre, Malaysia
Medtronic

Unknown

Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy

Type 2 Diabetes Mellitus

Malaysia
Novo Nordisk A/S

Completed

Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes (BEGIN™)

Diabetes | Diabetes Mellitus, Type 1

United States, France, United Kingdom, Russian Federation, Germany, South Africa
Novo Nordisk A/S

Completed

Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes (BEGIN™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
Hoffmann-La Roche
Roche Diagnostics

Completed

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Diabetes Mellitus Type 2, Diabetes Mellitus Type 1

Germany
National Research Council, Spain
Ministerio de Economía y Competitividad, Spain

Completed

Grape and Pomegranate Polyphenols in Postprandial Glucose and Related Parameters (POME-GRAPE-1)

Subjects With Abdominal Obesity

Spain
Novo Nordisk A/S

Completed

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes (BOOST™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
Novo Nordisk A/S

Completed

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Effect of NN5401 in Japanese Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes (BEGIN™)

Diabetes | Diabetes Mellitus, Type 1

United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
York University
Illinois Institute of Technology

Completed

Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes

Hypoglycemia | Physical Activity | Type1 Diabetes Mellitus
Rabin Medical Center

Completed

Overnight MD-Logic

Type 1 Diabetes

Germany, Israel, Slovenia
Novo Nordisk A/S

Completed

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes (REACH)

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes (PRESENT)

Diabetes Mellitus, Type 2 | Diabetes

Korea, Republic of
Novo Nordisk A/S

Completed

Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Monash University
Segi University

Completed

Making Ramadhan Fasting a Safer Experience With Technology Study

Diabetes Mellitus, Non-Insulin-Dependent

Malaysia
Novo Nordisk A/S

Completed

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes (BOOST™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
University of Virginia

Completed

Development of a Comprehensive AP Training Curriculum for Adults

Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

United States
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

Denmark
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; Harvard University; University...

Completed

At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation

Type 1 Diabetes Mellitus

United States
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
The First People's Hospital of Lianyungang
Hengrui Yuanzheng Bio-Technology Co., Ltd.

Unknown

Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Excluding T Cell Lymphoma

China
Hayat Pharmaceutical Co. PLC
Jordan University of Science and Technology

Completed

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome | Hypovitaminosis D

Jordan
Medical University of Warsaw

Unknown

Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

Diabetes type1

Poland
CeQur Corporation

Completed

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Terminated

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
University Hospital, Brest

Completed

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump (BOLUS)

Diabetes Type 1

France
Perle Bioscience, Inc.

Withdrawn

The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes (IIT)

Type 1 Diabetes
St Vincent's Hospital Melbourne
Juvenile Diabetes Research Foundation; Medtronic

Completed

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

Type 1 Diabetes

Australia
Swiss Federal Institute of Technology
PATH

Completed

The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate (Rice_FeZn)

Iron Deficiency

Switzerland
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; University of California...

Completed

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

Special Survey for Patients With Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
Hoffmann-La Roche

Completed

Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate

Diabetes Mellitus Type 1

Germany
Hoffmann-La Roche

Completed

A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine

Diabetes Mellitus Type 1

Italy

3

Subscribe